Furthermore, manipulation of gut microbiota or knockdown of FMO3 in insulin-resistant mice inhibited TMAO production, reduced PERK activation and suppressed FoxO1 in the liver, which may prevent the development of hyperglycemia [11, 51]. Here, FMO3 is linked to Hyperglycemia.